254 related articles for article (PubMed ID: 15888743)
21. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Eberhardt WE; De Ruysscher D; Weder W; Le Péchoux C; De Leyn P; Hoffmann H; Westeel V; Stahel R; Felip E; Peters S;
Ann Oncol; 2015 Aug; 26(8):1573-88. PubMed ID: 25897013
[TBL] [Abstract][Full Text] [Related]
22. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
23. Recent advances and future perspectives in the management of lung cancer.
Krupnick AS; Kreisel D; Hope A; Bradley J; Govindan R; Meyers B
Curr Probl Surg; 2005 Aug; 42(8):540-610. PubMed ID: 16087000
[No Abstract] [Full Text] [Related]
24. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
25. [35th Congress of the American Society of Clinical Oncology, Atlanta, USA, 15-18 May 1999. Non-small-cell lung tumors].
Foggi P
Clin Ter; 1999; 150(3):181-6. PubMed ID: 10528429
[No Abstract] [Full Text] [Related]
26. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
27. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
[No Abstract] [Full Text] [Related]
28. Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?
Konopa K
Ann Oncol; 2010 Oct; 21 Suppl 7():vii199-202. PubMed ID: 20943615
[TBL] [Abstract][Full Text] [Related]
29. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
30. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
32. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
[No Abstract] [Full Text] [Related]
33. Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.
Yang H; Lin Y; Liang Y
Curr Treat Options Oncol; 2017 Aug; 18(9):54. PubMed ID: 28795312
[TBL] [Abstract][Full Text] [Related]
34. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Sørensen M; Pijls-Johannesma M; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v120-5. PubMed ID: 20555060
[No Abstract] [Full Text] [Related]
35. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
Sweeney CJ; Sandler AB
Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
[TBL] [Abstract][Full Text] [Related]
36. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma.
Stupp R; Pavlidis N; Jelic S;
Ann Oncol; 2005; 16 Suppl 1():i64-5. PubMed ID: 15888760
[No Abstract] [Full Text] [Related]
37. Singapore Cancer Network (SCAN) Guidelines for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
Singapore Cancer Network (SCAN) Lung Cancer Workgroup
Ann Acad Med Singap; 2015 Oct; 44(10):440-8. PubMed ID: 26763062
[TBL] [Abstract][Full Text] [Related]
38. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
[TBL] [Abstract][Full Text] [Related]
39. [Our experience with patients operated after neoadjuvant therapy].
Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of localised forms of non small cell bronchial cancers: perspectives in 20003].
Depierre A; Quoix E; Milleron B
Rev Mal Respir; 2003 Apr; 20(2 Pt 1):173-6. PubMed ID: 12844012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
